Log in

Relevant bibliographies by topics / Central venous thrombosis / Journal articles

To see the other types of publications on this topic, follow the link: Central venous thrombosis.

Journal articles on the topic 'Central venous thrombosis'

Author: Grafiati

Published: 5 June 2025

Last updated: 1 August 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Central venous thrombosis.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Demey, Hendrik E., Guy Lambrecht, Greta Moorkens, Peter Michielsen, Jef Van Den Ende, and Leo L. Bossaert. "Thrombolysis in Central Splanchnic Thrombosis." Journal of Intensive Care Medicine 12, no. 5 (1997): 269–75. http://dx.doi.org/10.1177/088506669701200508.

Full text

Abstract:

We present 4 patients treated with streptokinase for different forms of abdominal venous thrombosis. Two patients suffered from central splanchnic venous thrombosis (superior mesenteric vein and bilateral iliac veins in Patient A, portal and superior mesenteric veins in Patient B). Both patients' presenting complaint was abdominal pain. In both, a temporary infection-associated circulating lupus anticoagulant presumably caused this condition. Two other patients presented with isolated portal vein thrombosis without lupus anticoagulant. Thrombolysis with high dose streptokinase (9 MU over 6 hou

APA, Harvard, Vancouver, ISO, and other styles

2

Wever, M. L. G., K. D. Liem, W. B. Geven, and R. B. Tanke. "Urokinase Therapy in Neonates with Catheter Related Central Venous Thrombosis." Thrombosis and Haemostasis 73, no. 02 (1995): 180–85. http://dx.doi.org/10.1055/s-0038-1653748.

Full text

Abstract:

SummaryThe results of fibrinolytic therapy with urokinase were evaluated in 26 neonates with catheter related central venous thrombosis. Complete thrombolysis could be achieved in 13 patients (50%), partial thrombolysis in 3 patients (12%). No effect was seen in 10 patients (38%). Therapy success was influenced by age, size and location of the thrombus. Coincidence of infection occurred in 16 patients (62%). Mild hemorrhagic complications were seen in 2 patients (8%), no other significant side effects were observed. Nine patients with residual thrombosis were treated with oral anticoagulants f

APA, Harvard, Vancouver, ISO, and other styles

3

Gollin, Gerald, Barbara Ward, George H. Meier, Bauer E. Sumpio, and Richard J. Gusberg. "Central Splanchnic Venous Thrombosis." Journal of Clinical Gastroenterology 18, no. 2 (1994): 109–13. http://dx.doi.org/10.1097/00004836-199403000-00005.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Borges, Cláudia, António Antunes, Catarina Pereira, et al. "P0401 CENTRAL VENOUS THROMBOSIS." European Journal of Internal Medicine 20 (May 2009): S136. http://dx.doi.org/10.1016/s0953-6205(09)60421-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

TOROSIAN, MICHAEL H., STEVEN MERANZE, JAMES L. MULLEN, and GORDON MCLEAN. "Central Venous Access with Occlusive Superior Central Venous Thrombosis." Annals of Surgery 203, no. 1 (1986): 30–33. http://dx.doi.org/10.1097/00000658-198601000-00006.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Geerts, William. "Central venous catheter–related thrombosis." Hematology 2014, no. 1 (2014): 306–11. http://dx.doi.org/10.1182/asheducation-2014.1.306.

Full text

Abstract:

Abstract Thrombotic complications associated with the use of central venous catheters (CVCs) are common and lead to distressing patient symptoms, catheter dysfunction, increased risk of infections, long-term central venous stenosis, and considerable costs of care. Risk factors for catheter-related thrombosis include use of larger, multilumen, and peripherally inserted catheters in patients with cancer receiving chemotherapy. Symptomatic catheter-related thrombosis is treated with anticoagulation, generally without removing the catheter. The intensity and duration of anticoagulation depend on t

APA, Harvard, Vancouver, ISO, and other styles

7

Obeso, Andrés, Laura Romero Vázquez, and Jorge Fernández Noya. "Chylothorax and Central Venous Thrombosis." JACC: Case Reports 3, no. 14 (2021): 1576–78. http://dx.doi.org/10.1016/j.jaccas.2021.07.026.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Lowell, Jeffrey A., and Albert Bothe. "Central Venous Catheter Related Thrombosis." Surgical Oncology Clinics of North America 4, no. 3 (1995): 479–92. http://dx.doi.org/10.1016/s1055-3207(18)30439-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Park, Christina K., Bosco A. Paes, Kim Nagel, Anthony K. Chan, and Prashanth Murthy. "Neonatal central venous catheter thrombosis." Blood Coagulation & Fibrinolysis 25, no. 2 (2014): 97–106. http://dx.doi.org/10.1097/mbc.0b013e328364f9b0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Yacopetti, Nicholas. "Central Venous Catheter-Related Thrombosis." Journal of Infusion Nursing 31, no. 4 (2008): 241–48. http://dx.doi.org/10.1097/01.nan.0000326833.59655.9e.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Kröger, K., C. Schelo, C. Gocke, and G. Rudofsky. "Colour Doppler Sonographic Diagnosis of Upper Limb Venous Thromboses." Clinical Science 94, no. 6 (1998): 657–61. http://dx.doi.org/10.1042/cs0940657.

Full text

Abstract:

1. Upper limb venous thromboses are considered to be a rare event, but in large hospitals with a lot of patients who receive aggressive intravenous therapy the number of thromboses seem to increase. 2. We have analysed all the cases of upper limb venous thrombosis which occurred at the Essen University Hospital between the years of 1992–1996. All patients were examined using colour Doppler sonography. 3. Out of 827 patients that were examined, a thrombosis was diagnosed in 334 cases. The subclavian vein was involved in 69% of all thromboses. Isolated jugular vein thrombosis was found in 17% of

APA, Harvard, Vancouver, ISO, and other styles

12

Bhargava, M., S. Broccard, Y. Bai, B. Wu, EH Dincer, and A. Broccard. "Risk factors for peripherally inserted central catheter line–related deep venous thrombosis in critically ill intensive care unit patients." SAGE Open Medicine 8 (January 2020): 205031212092923. http://dx.doi.org/10.1177/2050312120929238.

Full text

Abstract:

Introduction: Central venous access using peripherally inserted central catheters is frequently used for patients receiving intravenous medications in the hospital or outpatients. Although there are several benefits of peripherally inserted central catheters, such as ease of insertion, low procedure-related risk and higher patient satisfaction, there are complications associated with peripherally inserted central catheter use. Despite some studies evaluating peripherally inserted central catheter line–related complications, the factors associated with peripherally inserted central catheter–rel

APA, Harvard, Vancouver, ISO, and other styles

13

Faustino, Edward. "Central Venous Catheter-Associated Deep Venous Thrombosis in Critically Ill Children." Seminars in Thrombosis and Hemostasis 44, no. 01 (2017): 052–56. http://dx.doi.org/10.1055/s-0037-1603938.

Full text

Abstract:

AbstractThe presence of a central venous catheter and admission to the intensive care unit are the most important risk factors for deep venous thrombosis (DVT) in children. At least 18% of critically ill children with a catheter develop radiologically confirmed catheter-associated thrombosis. Clinically apparent thrombosis occurs in 3% of critically ill children with a catheter and is associated with 8 additional days of mechanical ventilation. Even when the thrombus is initially asymptomatic, 8 to 18% of critically ill children with catheter-associated thrombosis develop postthrombotic syndro

APA, Harvard, Vancouver, ISO, and other styles

14

Davis, CL. "Upper extremity venous thrombosis and central venous catheters." Critical Care Nurse 11, no. 8 (1991): 16–22. http://dx.doi.org/10.4037/ccn1991.11.8.16.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Turan, Tanya N., Valérie Biousse, and Nancy J. Newman. "Central Retinal Venous Occlusion and Cerebral Venous Thrombosis." Archives of Neurology 64, no. 4 (2007): 609. http://dx.doi.org/10.1001/archneur.64.4.609-a.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Teter, Katherine, Frank Arko, Patrick Muck, et al. "Aspiration thrombectomy for the management of acute deep venous thrombosis in the setting of venous thoracic outlet syndrome." Vascular 28, no. 2 (2019): 183–88. http://dx.doi.org/10.1177/1708538119895833.

Full text

Abstract:

Objectives Venous thoracic outlet syndrome, known by the eponym Paget–Schroetter syndrome, is seen in healthy, young individuals with “effort-induced thrombosis.” Endovascular therapies, including catheter-directed thrombolysis, have been described in the acute management of the upper extremity deep venous thrombosis; however, we assessed the technical success of treating this entity using a mechanical aspiration thrombectomy system. Methods This was a multi-center retrospective review of patients with venous thoracic outlet syndrome with acute thrombosis treated with the Indigo continuous asp

APA, Harvard, Vancouver, ISO, and other styles

17

Ruud, Ellen, Henrik Holmstrøm, Einar Hopp, and Finn Wesenberg. "Central Line-Associated Venous Late Effects in Children without Any Prior History of Thrombosis - A Cross-Sectional Study of Children Previously Treated for Malignant or Hematological Diseases." Blood 106, no. 11 (2005): 4118. http://dx.doi.org/10.1182/blood.v106.11.4118.4118.

Full text

Abstract:

Abstract Background: The frequency of asymptomatic central line-associated thromboses is high and well recognised among children with cancer, while the long-term consequences are mainly unknown. In a cross-sectional study, we have evaluated clinical and radiological venous outcome in children with previous long-standing intravascular catheters. Methods: The study enrolled 71 children previously treated for malignant or haematological diseases, 4–180 (median 37) months after removal of their central lines. The central lines had been placed in a jugular vein for a minimum of six months, and none

APA, Harvard, Vancouver, ISO, and other styles

18

Fraschini, G., J. Jadeja, M. Lawson, F. A. Holmes, H. C. Carrasco, and S. Wallace. "Local infusion of urokinase for the lysis of thrombosis associated with permanent central venous catheters in cancer patients." Journal of Clinical Oncology 5, no. 4 (1987): 672–78. http://dx.doi.org/10.1200/jco.1987.5.4.672.

Full text

Abstract:

We assessed the efficacy of local fibrinolytic therapy in 35 axillary-subclavian vein thromboses (SVT) that occurred in cancer patients with percutaneous central venous catheters (CVC). These catheters were indwelling for a median of 1 month (range, one day to 10 months) before thrombosis developed. Urokinase was administered at a dose of 500 to 2,000 U/kg/h. Complete lysis occurred in 25 of 30 thrombi that were directly infused, after a median of four days. Complete lysis occurred in one of 12 thrombi that could not be directly infused with urokinase and in two of six with associated phlebiti

APA, Harvard, Vancouver, ISO, and other styles

19

Murphy, P. T., and N. O'Connor. "Low risk of central venous thrombosis with nontunnelled central venous catheters." Clinical & Laboratory Haematology 23, no. 3 (2001): 187–88. http://dx.doi.org/10.1046/j.1365-2257.2001.00362.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Sloot, S., J. Van Nierop, JJ Kootstra, C. Wittens, and WM Fritschy. "Bilateral catheter-directed thrombolysis in a patient with deep venous thrombosis caused by a hypoplastic inferior vena cava." Phlebology: The Journal of Venous Disease 30, no. 4 (2014): 293–95. http://dx.doi.org/10.1177/0268355514524194.

Full text

Abstract:

Introduction Deep venous thrombosis treatment using catheter-directed thrombolysis is advocated over systemic thrombolysis because it reduces bleeding complications. With the development of a catheter that combines ultrasound vibrations and the local delivering of thrombolytics, new and safer treatments appear that are suitable for more complex problems. Report An adolescent male presented with bilateral iliofemoral thrombosis based on a hypoplastic inferior vena cava that had existed for more than two weeks. He was succesfully treated by bilateral ultrasound-accelerated catheter-directed thro

APA, Harvard, Vancouver, ISO, and other styles

21

Rajasekhar, Anita, and Michael B. Streiff. "How I treat central venous access device–related upper extremity deep vein thrombosis." Blood 129, no. 20 (2017): 2727–36. http://dx.doi.org/10.1182/blood-2016-08-693671.

Full text

Abstract:

AbstractCentral venous access device (CVAD)-related thrombosis (CRT) is a common complication among patients requiring central venous access as part of their medical care. Complications of CRT include pulmonary embolism, recurrent deep venous thrombosis, loss of central venous access, and postthrombotic syndrome. Patient-, device-, and treatment-related factors can influence the risk of CRT. Despite numerous randomized controlled trials, the clinical benefit of pharmacologic thromboprophylaxis for the prevention of CRT remains to be established. Therefore, minimizing patient exposure to known

APA, Harvard, Vancouver, ISO, and other styles

22

Gwozdz, Adam M., Justinas Silickas, Alberto Smith, Prakash Saha, and Stephen A. Black. "Endovascular Therapy for Central Venous Thrombosis." Methodist DeBakey Cardiovascular Journal 14, no. 3 (2018): 214. http://dx.doi.org/10.14797/mdcj-14-3-214.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Abou-Raya, Anna, and Suzan Abou-Raya. "Central Venous Thrombosis in Behçet's Disease." Angiology 59, no. 2 (2008): 248–50. http://dx.doi.org/10.1177/0003319707303891.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Jacobs, Brian R. "Central venous catheter occlusion and thrombosis." Critical Care Clinics 19, no. 3 (2003): 489–514. http://dx.doi.org/10.1016/s0749-0704(03)00002-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Mesbah, Ahmed, Ahmed Abd El-Basset, Hala Nagy, and Khaled Talaat. "Central Venous Catheter-Associated Deep Venous Thrombosis in Critically Ill Children in Tanta Pediatric Intensive Care Unit." Journal of Advances in Medicine and Medical Research 35, no. 19 (2023): 296–304. http://dx.doi.org/10.9734/jammr/2023/v35i195163.

Full text

Abstract:

Background: The largest prevalence of CVC-related thrombosis occurs in infants under the age of one year, which is likely due to the infant's smaller diameter vessels. In addition, CVC-related thromboses are more likely to occur in patients with malignancy, critical illness, congenital heart disease, systemic infection, total parenteral nutrition, trauma, and in patients admitted to the Neonatal Intensive Care Unit. Central line occlusion or frequent central line infections are sometimes the first sign of thrombosis and should increase suspicion of a VTE. In neonates with catheter-related thro

APA, Harvard, Vancouver, ISO, and other styles

26

Lee, Young Hoon, and Jei Kim. "Central Retinal Venous Occlusion and Cerebral Venous Thrombosis—Reply." Archives of Neurology 64, no. 4 (2007): 609. http://dx.doi.org/10.1001/archneur.64.4.609-b.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Keung, Yi-Kong, Everardo Cobos, Annabel Barber, et al. "Relationship Between Activated Protein C Resistance and Central Venous Device-Related Complications." Clinical and Applied Thrombosis/Hemostasis 3, no. 2 (1997): 133–36. http://dx.doi.org/10.1177/107602969700300212.

Full text

Abstract:

We studied the relationship between activated protein C (APC) resistance and the central venous devices (CVD)-related complications in 61 cancer patients (44 females `and 17 males, median age 50 years, 71 CVD) from November 1994 to November 1995. Two patients (3.3%) had APC resistance, i.e., APC ratio < 2. Twelve episodes of bactercmia, 8 site infections, 31 cases of CVD dysfunction requiring urokinase (UK), and 3 CVD-retated thromboses were noted. With Cox's proportional hazard models, low APC ratios and high d-dimer levels were significantly associated with CVD-related bacteremia (p = 0.0

APA, Harvard, Vancouver, ISO, and other styles

28

Gurley, Melissa B., Teresa S. King, and Fong Y. Tsai. "Sigmoid Sinus Thrombosis Associated with Internal Jugular Venous Occlusion: Direct Thrombolytic Treatment." Journal of Endovascular Therapy 3, no. 3 (1996): 306–14. http://dx.doi.org/10.1177/152660289600300311.

Full text

Abstract:

Purpose: To report our experience with transfemoral direct venous thrombolysis and angioplasty to treat central venous and dural sinus occlusion. The cases presented are rare examples of internal jugular occlusion associated with sigmoid sinus thrombosis. Methods and Results: Two middle-aged, symptomatic female patients were diagnosed with sigmoid sinus and internal jugular vein thrombosis. Venography was performed from a contralateral transfemoral approach, followed immediately by urokinase infusion directly to the occlusion using an intermittent “burst-bolus” technique. Successful thrombolys

APA, Harvard, Vancouver, ISO, and other styles

29

Smalisz-Skrzypczyk, Katarzyna, Anna Klukowska, Katarzyna Pawelec, and Michal Matysiak. "Thrombosis Risk Factors Assessment In Children Treated For Acute Lymphoblastic Leukemia." Blood 122, no. 21 (2013): 4791. http://dx.doi.org/10.1182/blood.v122.21.4791.4791.

Full text

Abstract:

The aim of the study was to evaluate factors predisposing to thrombosis in children treated for acute lymphoblastic leukemia according to ALL IC BFM 2002. An analysis of 30 cases of thrombosis in 210 children (14%) treated due to ALL in the Department in years 2007-2011 was carried out. Age at onset, location, cause and treatment methods were taken into consideration. All analyzed patients underwent screening for congenital thrombophilia. The age of patients ranged from 1.5 to 16 years with the median of 7.5 years. Arterial thrombosis occurred in 1 person (3%), venous thrombosis in 29 (97%) pa

APA, Harvard, Vancouver, ISO, and other styles

30

Sarcev, Ivan, Branislava Petronijevic-Sarcev, and Sinisa Mirkovic. "Nonsyndromic impacted triple supernumerary teeth in the maxilla, including single dens in dente malformation: A case report with a two-year follow-up." Vojnosanitetski pregled 79, no. 5 (2022): 516–20. http://dx.doi.org/10.2298/vsp201115140s.

Full text

Abstract:

Introduction. A percutaneous transhepatic approach has been used to place tunneled catheters for hemodialysis in the inferior vena cava. This route through the suprahepatic vein could be used to place a tunnelled catheter for permanent hemodialysis without complications and with an excellent permeability rate. Case report. From 2011 to 2020 at the Military Medical Academy, we treated 4 patients with the transhepatic central venous catheter for hemodialysis. All of them had exhausted approaches during the period of hemodialysis. Arterio-venous fistulas thrombosed on the arms, subclavian vein th

APA, Harvard, Vancouver, ISO, and other styles

31

Schmidt, Barbara, and Maureen Andrew. "Neonatal Thrombosis: Report of a Prospective Canadian and International Registry." Pediatrics 96, no. 5 (1995): 939–43. http://dx.doi.org/10.1542/peds.96.5.939.

Full text

Abstract:

Objective. We sought to obtain representative data on the risk factors, diagnosis, current management, and short-term outcome of neonatal thrombosis. Research Design. A case registry was established at McMaster University. Standardized questionnaires were mailed to collaborators at participating centers every 4 to 6 months. Setting. Eighty-five level III and modified level II neonatal units in North America, Europe, and Australia were invited to join the registry. Patients. Eligible infants were born between January 1990 and June 1993. Large-vessel thrombosis was diagnosed during the first mon

APA, Harvard, Vancouver, ISO, and other styles

32

Clark, Roberta. "Neonatal Thrombosis." Neonatal Network 23, no. 3 (2004): 57–68. http://dx.doi.org/10.1891/0730-0832.23.3.57.

Full text

Abstract:

NEONATAL VASCULAR THROMBOSIS is rare; however, it is emerging as a more frequent problem in tertiary neonatal care.1Both the incidence and severity of thromboembolic events are increasing in children, with newborns being the largest group affected.2A 1995 Canadian study estimated that the incidence of clinically diagnosed cases of neonatal thrombosis was 2.4 per 1,000 admissions.3A two-year study published in Germany in 1997 reported 5.1 per 100,000 births.4The first study reported that thrombotic disease diagnosed in neonates is most commonly associated with the presence of an indwelling intr

APA, Harvard, Vancouver, ISO, and other styles

33

Haggstrom, Lucy, Gurdeep Parmar, and Daniel Brungs. "Central Venous Catheter Thrombosis in Cancer: A Multi-Centre Retrospective Study Investigating Risk Factors and Contemporary Trends in Management." Clinical Medicine Insights: Oncology 14 (January 2020): 117955492095309. http://dx.doi.org/10.1177/1179554920953097.

Full text

Abstract:

Objectives: Central venous access is needed to facilitate chemotherapy for many cancer patients. Central venous catheter-related thrombosis (CVCT) is a major complication that can cause significant morbidity and mortality. We sought to explore the rate of CVCT in a general cancer population in Australia and to identify factors associated with increased risk of thrombosis. Design: This is a multi-centre retrospective cohort study. Setting and participants: We analysed key patient, treatment, and cancer-related factors for 317 patients with cancer and central venous catheters inserted for system

APA, Harvard, Vancouver, ISO, and other styles

34

Hecking, Aschwanden, Dickenmann, et al. "Efficient haemodialysis despite complete central venous thrombosis." Vasa 35, no. 4 (2006): 243–44. http://dx.doi.org/10.1024/0301-1526.35.4.243.

Full text

Abstract:

Two cases with a fully functional haemodialysis access, in spite of complete thrombotic occlusion of the ipsilateral subclavian and/or brachiocephalic vein are reported. The coincidentally detected complete venous occlusions may indicate that occult venous stenosis or thrombosis is more frequent than generally assumed. In order to avoid deterioration of the haemodynamic situation interventions may be withheld unless clinical problems related to a diminished outflow occur.

APA, Harvard, Vancouver, ISO, and other styles

35

Zhu, Weiwei, Hua Zhang, and Yan Xing. "Clinical Characteristics of Venous Thrombosis Associated with Peripherally Inserted Central Venous Catheter in Premature Infants." Children 9, no. 8 (2022): 1126. http://dx.doi.org/10.3390/children9081126.

Full text

Abstract:

Background: This study aimed to analyze clinical characteristics and risk factors for peripherally inserted central catheter (PICC) placement in premature infants. Materials: This study included seven premature infants who were hospitalized in the neonatal intensive care unit (NICU) of Peking University Third Hospital from 1 January 2014–30 June 2021, and suffered PICC-related venous thrombosis. The control group included premature infants (n = 56) matched (1:8) by the following: Did not experience venous thrombosis; born with a similar gestational age (±2 w), birth weight (±200 g); and receiv

APA, Harvard, Vancouver, ISO, and other styles

36

Sousa Nanji, Liliana, André Torres Cardoso, João Costa, and António Vaz-Carneiro. "Analysis of the Cochrane Review: Thrombolysis for Acute Deep Vein Thrombosis. Cochrane Database Syst Rev. 2014,1: CD002783." Acta Médica Portuguesa 28, no. 1 (2015): 12. http://dx.doi.org/10.20344/amp.6286.

Full text

Abstract:

<p>The standard treatment for acute deep vein thrombosis (DVT) targets to reduce immediate complications, however thrombolysis could reduce the long-term complications of post-thrombotic syndrome in the affected limb. This systematic review aimed to assess the effects of thrombolytic therapy and anticoagulation <em>versus </em>anticoagulation in people with deep vein thrombosis of the lower limb through the effects on pulmonary embolism, recurrent deep vein thrombosis, major bleeding, post-thrombotic complications, venous patency and venous function. The Cochrane Peripheral V

APA, Harvard, Vancouver, ISO, and other styles

37

Sakaguchi, Yoshiro. "Peripherally inserted central venous catheter-related thrombosis." Journal of the Japanese Society of Intensive Care Medicine 29, no. 3 (2022): 209–10. http://dx.doi.org/10.3918/jsicm.29_209.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Ghanem, Ghazi, Javier Adachi, Xiang-Yang Han, and Issam Raad. "Central Venous Catheter–Related Streptomyces Septic Thrombosis." Infection Control & Hospital Epidemiology 28, no. 05 (2007): 599–601. http://dx.doi.org/10.1086/513619.

Full text

Abstract:

Streptomycesspecies are part of the actinomycetes group. They have rarely been reported as a cause of invasive infection. We report a case of catheter-relatedStreptomycesbacteremia complicated by severe sepsis and septic thrombosis. We also present a brief review of the literature onStreptomycesbacteremia.

APA, Harvard, Vancouver, ISO, and other styles

39

Vellalacheruvu, N., N. Monigari, T. Devasia, and H. Kareem. "Central vein stenosis masquerading as venous thrombosis." Case Reports 2014, mar24 1 (2014): bcr2014203690. http://dx.doi.org/10.1136/bcr-2014-203690.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Revel-Vilk, Shoshana. "Central Venous Line-Related Thrombosis in Children." Acta Haematologica 115, no. 3-4 (2006): 201–6. http://dx.doi.org/10.1159/000090936.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Hurst, Robert W., Scott R. Kerns, Joan Mcllhenny, Tae Sung Park, and Wayne S. Cail. "Neonatal Dural Venous Sinus Thrombosis Associated with Central Venous Catheterization." Journal of Computer Assisted Tomography 13, no. 3 (1989): 504–7. http://dx.doi.org/10.1097/00004728-198905000-00027.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Hammes, Mary, Amishi Desai, Shravani Pasupneti, et al. "Central venous catheters: incidence and predictive factors of venous thrombosis." Clinical Nephrology 84 (2015), no. 07 (2015): 21–28. http://dx.doi.org/10.5414/cn108347.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Nañez-Terreros, Homero, Jose C. Jaime-Perez, Linda E. Muñoz-Espinoza, et al. "D-dimer from central and peripheral blood samples in asymptomatic central venous catheter-related thrombosis in patients with cancer." Phlebology: The Journal of Venous Disease 34, no. 1 (2018): 52–57. http://dx.doi.org/10.1177/0268355518772171.

Full text

Abstract:

Objectives To evaluate the usefulness of a negative D-dimer in peripheral or central venous blood to screen for asymptomatic catheter-related thrombosis in cancer patients. Methods D-dimer was measured in blood from central venous catheter and peripheral venous samples in 48 patients with cancer. Asymptomatic catheter-related thrombosis was identified via Doppler ultrasound. Bland and Altman’s limits of agreement analysis was used to compare sample sites. Sensitivity and specificity of D-dimer was calculated. Results Overall, 33 of the central samples and 32 of the peripheral samples had D-dim

APA, Harvard, Vancouver, ISO, and other styles

44

Lamza, N.V., O.V. Kovtunenko, G.K. Morgachova, et al. "Peculiarities of the differential diagnosis of different types of cerebral sinus and vein thrombosis in patients with ENT organs involvement." Medicni perspektivi 27, no. 1 (2022): 77–86. https://doi.org/10.26641/2307-0404.2022.1.254331.

Full text

Abstract:

The paper is devoted to the problems of diagnosis of septic and aseptic forms of central venous thrombosis. The aim of the study was to study the clinical manifestation and lesions of the ear, nose and throat, in patients with aseptic central venous thrombosis in order to increase the efficiency of differential diagnosis of various forms of thrombosis and to determine the tactics of further treatment of patients with this disease. Variants of manifestation of lesions of Lesions of the ear, nose and throat were studied in 14 patients with aseptic central venous thrombosis who were hospitalized

APA, Harvard, Vancouver, ISO, and other styles

45

Elezovic, Ivo. "Role of gene polymorphism in development of thromboses." Srpski arhiv za celokupno lekarstvo 134, Suppl. 1 (2006): 64–71. http://dx.doi.org/10.2298/sarh06s1064e.

Full text

Abstract:

The development of thromboses is one of the most common causes of morbidity and mortality in the Western world. The perturbation of haemostasis is the central event in the pathogenesis of all thromboses. Most patients with thromboses have no recognisable associated haemostatic disorders. However, some patients do manifest hereditary hypercoagulable states, which contribute to the development of thromboses as well as other clinical manifestations, such as miscarriages and foetal complications. The major determinants of thrombosis include both environmental influences and genetic factors. Transi

APA, Harvard, Vancouver, ISO, and other styles

46

Fusaro, F., M. G. Scarpa, R. Lo Piccolo, and G. F. Zanon. "Central Venous Access in Pediatric Patients." Journal of Vascular Access 2, no. 3 (2001): 125–28. http://dx.doi.org/10.1177/112972980100200308.

Full text

Abstract:

Occlusion of traditional sites for central venous cannulation is a challenging problem in patients that require a permanent central venous line for chronic administration of nutrients or drugs. In rare cases, extensive central venous thrombosis of the superior and inferior vena cava may preclude catheterization, and uncommon routes should be used. We describe our approach for placement of chronic central venous lines in two pediatric patients with short bowel syndrome and extensive caval occlusion.

APA, Harvard, Vancouver, ISO, and other styles

47

Cote, Julie, Olivier Dumas, Christine Demers, and Julie Lemieux. "Prevalence, risk factors, treatment and outcomes of catheter-related thrombosis in patients with malignancies." Journal of Clinical Oncology 31, no. 15_suppl (2013): e17517-e17517. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.e17517.

Full text

Abstract:

e17517 Background: Tunnelled catheters (Leonard, BARD) and peripherally inserted central catheters (Piccline, BARD) are used for intravenous therapies in patients with malignancies. Thrombosis is a well known complication, but risk factors are not clearly established. The objective the incidence, risk factors, therapeutic approaches and complications of catheter-related thrombosis among patients with malignancies. Methods: Medical charts of patients with malignancies and Leonard or Piccline inserted, from August 2002 to December 2006 at Hôpital de l’Enfant-Jésus (Québec City, Canada), were ret

APA, Harvard, Vancouver, ISO, and other styles

48

Leung, Amy, Clare Heal, Jennifer Banks, Breanna Abraham, Gian Capati, and Casper Pretorius. "The Incidence of Peripheral Catheter-Related Thrombosis in Surgical Patients." Thrombosis 2016 (January 24, 2016): 1–6. http://dx.doi.org/10.1155/2016/6043427.

Full text

Abstract:

Background. Central venous catheters and peripherally inserted central catheters are well established risk factors for upper limb deep vein thrombosis. There is limited literature on the thrombosis rates in patients with peripheral catheters. A prospective observational study was conducted to determine the incidence of peripheral catheter-related thrombosis in surgical patients. Methods. Patients deemed high risk for venous thrombosis with a peripheral catheter were considered eligible for the study. An ultrasound was performed on enrolment into the study and at discharge from hospital. Partic

APA, Harvard, Vancouver, ISO, and other styles

49

Duerksen, Donald R. "Central venous thrombosis in patients receiving long-term parenteral nutrition." Applied Physiology, Nutrition, and Metabolism 33, no. 1 (2008): 32–38. http://dx.doi.org/10.1139/h07-153.

Full text

Abstract:

Long-term parenteral nutrition (PN) is administered to patients who are unable to use their gastrointestinal tract to absorb sufficient nutrients and water to maintain their nutritional status. Patients receiving long-term parenteral nutrition are at risk of numerous complications including thrombosis of the central venous catheter used to provide nutrition. Central venous access is essential to the successful delivery of long-term PN. One of the strategies to lessen the frequency of this complication is anticoagulation therapy with warfarin. The effect of warfarin in preventing this complicat

APA, Harvard, Vancouver, ISO, and other styles

50

Saijo, Fumito, Yoshinobu Odaka, Mitsuhisa Mutoh, Yu Katayose, and Hiromi Tokumura. "A novel technique of axillary vein puncture involving peripherally inserted central venous catheters for a small basilic vein." Journal of Vascular Access 19, no. 3 (2018): 311–15. http://dx.doi.org/10.1177/1129729818757974.

Full text

Abstract:

Purpose: Peripherally inserted central venous catheters are some of the most useful devices for vascular access used globally. Peripherally inserted central venous catheters have a low rate of fatal mechanical complications when compared to non-tunnel central venous catheters. However, as peripherally inserted central venous catheter access requires a smaller vein, there is a high risk of thrombosis. The axillary vein (confluence of the basilic and brachial veins) can serve as an access for cannulation. Moreover, as this vein is larger than the basilic or brachial vein, it might be a superior

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!